Phytotherapy in the context of Polycystic Ovary Syndrome: A narrative review
DOI:
https://doi.org/10.33448/rsd-v13i12.47655Keywords:
Polycystic Ovary Syndrome; Medicinal plants; Phytotherapy.Abstract
The use of medicinal plants for therapeutic purposes has records that may date back to 60,000 years BC, and Phytotherapy is used for various types of treatment in women's health, such as in Polycystic Ovary Syndrome (PCOS). PCOS is an endocrine, metabolic, and reproductive disorder that affects women of childbearing age. It is known that in addition to the synthetic drugs used to aid in the treatment of PCOS, a balanced diet and the practice of physical activities are great allies in the management of this syndrome, in addition, some medicinal plants can be used to contribute to the effective management of PCOS. The objective of this research was to review the literature, on species that have properties capable of positively influencing the metabolic and hormonal profile of patients with PCOS. This is a narrative review of the literature, whose searches were carried out in the Scielo, PubMed, and Google Scholar databases. The most frequently found species with applicability in the context of PCOS were cinnamon (Cinnamomum verum), saffron (Curcuma longa), marjoram (Origanum marjoram), fennel (Foeniculum vulgare Mill.) and soy isoflavones (Glycine max). Despite the benefits regarding metabolic and endocrine profiles with the use of such plant species, more clinical and experimental studies applied on this topic are necessary to better define the dosages and safety profiles of these medicinal plants with the potential to be used in the management of PCOS.
References
Almeida, A. P. F., & Assis, M. M. (2017). Efeitos colaterais e alterações fisiológicas relacionadas ao uso contínuo de anticoncepcionais hormonais orais. Revista Eletrônica Atualiza Saúde, 5(5), 85-93.
Almeida, M. Z., Lessa, G. M., Silva, M. Q. O. R., Cardoso, D. N., & Santos, F. A. (2011). Fitoterapia no SUS no Estado da Bahia: contribuição para valorização do conhecimento e das práticas tradicionais na rede básica de saúde. Revista Fitos, 6(1), 29-34.
Alves, M. L. S., Donne, R. D. D., Romano, R. M., & Romano, M. A. (2022). Polycystic ovary syndrome (PCOS), pathophysiology and treatment, a review. Research, Society and Development, 11(9), e25111932469. https://doi.org/10.33448/rsd-v11i9.32469.
Arentz, S., Smith, C. A., Abbott, J., Fahey, P., Cheema, B. S., & Bensoussan, A. (2017). Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): A randomized controlled trial. Phytotherapy Research, 31(9), 1330-1340.
Argenta, S. C., Argenta, L. C., Giacomelli, S. R., & Cezarotto, V. S. (2011). Plantas medicinais: Cultura popular versus ciência. Vivências: Revista Eletrônica de Extensão da Uri, 7(12), 51-60.
Barbosa, A. C. L., Hassimotto, N. M. A., Lajolo, F. M., & Genovese, M. I. (2006). Teores de isoflavonas e capacidade antioxidante da soja e produtos derivados. Ciência e Tecnologia de Alimentos, 26(4), 921-926.
Botelho, L. L. R., Cunha, C. A., & Macedo, M. (2011). O método da revisão integrativa nos estudos organizacionais. Gestão e Sociedade, 5(11), 121-136.
Brasil. (2006). Decreto nº 5.813, de 22 de junho de 2006. Aprova Política Nacional de Plantas Medicinais e Fitoterápicos. Diário Oficial da União, Brasília, Ministério da Saúde.
Brunton, L. L., et al. (2019). Goodman & Gilman: As bases farmacológicas da terapêutica (13ª ed.). McGaw Hill/Artmed. https://www.meulivro.biz/farmacologia/3102/as-bases-farmacologicas-da-terapeutica-de-goodman-gilman-13-ed-pdf/
.
Campos A. E., Leão M. E. B., & de Souza M. A. (2021). O impacto da mudança do estilo de vida em mulheres com síndrome dos ovários policísticos. Revista Eletrônica Acervo Saúde, 13(2), e4354. https://doi.org/10.25248/reas.e4354.2021.
Farkhad, S. A., & Khazali, H. (2019). Efeitos terapêuticos da fração isoflavona-aglicona da soja (Glycine max L. Merrill) em ratos com síndrome do ovário policístico induzida por valerato de estradiol como um estado inflamatório. Gynecological Endocrinology, 35, 1078–83.
FEBRASGO. (2019). Síndrome dos ovários policísticos: repercussões metabólicas de uma doença intrigante. Coleção FEBRASGO, 37(9).
FEBRASGO. (2023). Síndrome dos ovários policísticos (3ª ed., Série Orientações e Recomendações FEBRASGO, No. 1/Comissão Nacional Especializada em Ginecologia Endócrina). São Paulo: FEBRASGO.
Flores, P. D. (2022). Efeitos da suplementação de curcumina (Curcuma longa) nos marcadores de inflamação, estresse oxidativo e dano muscular induzido pelo exercício físico: uma revisão sistemática e metanálise. (Dissertação de Mestrado). Curso de Pós-Graduação em Educação Física, Universidade Federal de Pelotas, Pelotas.
Haj-Husein, T., Tukan, S., & Alkazaleh, F. (2016). The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: A randomised controlled pilot study. Journal of Human Nutrition and Dietetics, -, 1-7.
Hajimonfarednejad, M., et al. (2018). Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double‐blind placebo controlled clinical trial. Phytotherapy Research, 32(2), 1-8.
Haudum, C., et al. (2020). Impact of short-term isoflavone intervention in polycystic ovary syndrome (PCOS) patients on microbiota composition and metagenomics. Nutrients, 12(6), 1-22.
Heshmati, J., et al. (2020). The effects of curcumin supplementation on oxidative stress, Sirtuin-1 and peroxisome proliferator activated receptor γ coactivator 1α gene expression in polycystic ovarian syndrome (PCOS) patients: A randomized placebo-controlled clinical trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(2), 77-82.
Jamilian, M., & Asemi, Z. (2016). Os efeitos das isoflavonas de soja no estado metabólico de pacientes com síndrome do ovário policístico. The Journal of Clinical Endocrinology & Metabolism, 101(9), 3386–3394. https://doi.org/10.1210/jc.2016-1762.
Jamilian, M., et al. (2020). Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition ESPEN, 36, 128-133.
Kocaadam, B., & Sanlier, N. (2017). Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical Reviews in Food Science and Nutrition, 57(13), 2889–95.
Kort, D. H., & Lobo, R. A. (2014). Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: A randomized controlled trial. American Journal of Obstetrics and Gynecology, 211(5), 487.e1-6. https://doi.org/10.1016/j.ajog.2014.05.009.
Li, K., Chen, G., Hou, H., Liao, Q., Chen, J., Bai, H., Lee, S., Wang, C., Li, H., Cheng, L., & Ai, J. (2021). Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reproductive BioMedicine Online, 42(1), 260. https://doi.org/10.1016/j.rbmo.2020.09.020.
Lima, T. A., & Araújo, A. H. I. M. (2022). A síndrome do ovário policístico relacionada à resistência à insulina e os seus riscos associados: uma revisão narrativa. Revista JRG de Estudos Acadêmicos, 5(11), 309-316.
Maleki, V., Faghfouri, A. H., Tabrizi, F. P. F., Moludi, J., Saleh-Ghadimi, S., Jafari-Vayghan, H., & Qaisar, S. A. (2021). Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: A systematic review. Journal of Ovarian Research, 14(1), 130. https://doi.org/10.1186/s13048-021-00870-5.
Meena, M. (2019). Role of Foeniculum vulgare in PCOS: A review article. World Journal of Pharmaceutical Research, 8(10), 344–350.
Mokaberinejad, R., Rampisheh, Z., Aliasl, J., Akhtari, E., Moore, M., & Lewith, G. (2019). The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: A randomised clinical trial. Journal of Obstetrics and Gynaecology, 39(5), 652-658.
Nordi, J. B., Moresco, E., & Ortiz, M. E. P. (2024). Diagnosis of insulin resistance in polycystic ovary syndrome. Research, Society and Development, 13(2), e8513245028. https://doi.org/10.33448/rsd-v13i2.45028.
Parker, J., et al. (2022). Polycystic ovary syndrome: An evolutionary adaptation to lifestyle and the environment. International Journal of Environmental Research and Public Health, 19(3), 1336. https://doi.org/10.3390/ijerph19031336.
Quemel, G. K. C., et al. (2021). Revisão da literatura sobre o uso da Curcuma longa L. como terapêutica em processos inflamatórios. International Journal of Development Research, 11(5), 46856-46863.
Rababa'h, A. M., Matani, B. R., & Ababneh, M. A. (2020). The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats. Life Sciences, 261, 118353. https://doi.org/10.1016/j.lfs.2020.118353.
Rocha, L. P. B., et al. (2021). Uso de plantas medicinais: Histórico e relevância. Research, Society and Development, 10(10), 1-11.
Rother, E. T. (2007). Revisão sistemática X revisão narrativa. Acta Paulista de Enfermagem, 20(2), 5-6.
Santos, et al. (2024). Nutrição no tratamento da síndrome do ovário policístico. Research, Society and Development, 13(5). http://dx.doi.org/10.33448/rsd-v13i5.45772.
Shen, W., Qu, Y., Jiang, H., Wang, H., Pan, Y., Zhang, Y., Wu, X., Han, Y., & Zhang, Y. (2022). Therapeutic effect and safety of curcumin in women with PCOS: A systematic review and meta-analysis. Frontiers in Endocrinology (Lausanne), 13, 1051111. https://doi.org/10.3389/fendo.2022.1051111.
Siddiqui, S., Mateen, S., Ahmad, R., & Moin, S. (2022). A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). Journal of Assisted Reproduction and Genetics, 39(11), 2439-2473. https://doi.org/10.1007/s10815-022-02625-7.
Silva, I. S. T., et al. (2020). A associação da mudança no estilo de vida com a terapia farmacológica no tratamento da Síndrome dos Ovários Policísticos (SOP). Revista Eletrônica Acervo Saúde, 57, 1-10.
Silva, M. C. L. P., et al. (2020). Fitoterapia como intervenção em saúde da mulher: Revisão integrativa da literatura. Cogitare Enfermagem, 25, 1-14.
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic ovary syndrome: Etiology, current management, and future therapeutics. Journal of Clinical Medicine, 12, 1454. https://doi.org/10.3390/jcm12041454.
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020). Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocrine Reviews, 41(4), 538–576. https://doi.org/10.1210/endrev/bnaa010.
Taşkömür AT & Erten Ö. (2022). Relationship of inflammatory and metabolic parameters in adolescents with PCOS: BMI matched case-control study. Arch Endocrinol Metab, 66(3), 372-381.
Vagi, E.; Simándi, B.; Suhajda, A.; & Hethelyi, E. (2005). Essential oil composition and antimicrobial activity of Origanum majorana L. extracts obtaind with ethyl alcohol and supercritical carbon dioxide. Food Research Internacional, 38(1), 51-57.
Yazbek, P. B., Tezoto, J., Cassas, F., & Rodrigues, E. (2016). Plants used during maternity, menstrual cycle and other women’s health conditions among Brazilian cultures. Journal of Ethnopharmacology, 179(1). Disponível em: https://www.sciencedirect.com/science/article/pii/S0378874115301701
Zanardo, V. P. S.; Rambo, D. F.; & Schwanke, C. H. A. (2014). Canela (Cinnamomum sp) e seu efeito nos componentes da síndrome metabólica. Perspectiva Erechim, 38(0), 39-48.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Viviany Azevedo Gomes; Joana Ferreira dos Santos; Beatriz de Freitas Medeiros; Êmilly Mendes Angelino; Ysla Eduarda Oliveira Silva; Alana Brena Costa dos Santos; Ana Janaína Jeanine Martins de Lemos Jordão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
